Ultragenyx Pharmaceutical Inc. (RARE): Price and Financial Metrics
RARE Price/Volume Stats
| Current price | $50.99 | 52-week high | $60.37 |
| Prev. close | $50.99 | 52-week low | $34.06 |
| Day low | $50.83 | Volume | 680,600 |
| Day high | $51.84 | Avg. volume | 765,982 |
| 50-day MA | $55.70 | Dividend yield | N/A |
| 200-day MA | $47.86 | Market Cap | 4.70B |
RARE Stock Price Chart Interactive Chart >
Ultragenyx Pharmaceutical Inc. (RARE) Company Bio
Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company was founded in 2010 and is based in Novato, California.
RARE Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Continue Researching RARE
Want to do more research on Ultragenyx Pharmaceutical Inc's stock and its price? Try the links below:Ultragenyx Pharmaceutical Inc (RARE) Stock Price | Nasdaq
Ultragenyx Pharmaceutical Inc (RARE) Stock Quote, History and News - Yahoo Finance
Ultragenyx Pharmaceutical Inc (RARE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...